{"data":{"id":"us/21-cfr-58.41","jurisdiction":"us","citation":"21 CFR 58.41","heading":"General.","body":"Each testing facility shall be of suitable size and construction to facilitate the proper conduct of nonclinical laboratory studies. It shall be designed so that there is a degree of separation that will prevent any function or activity from having an adverse effect on the study.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER A—GENERAL","PART 58—GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES","Subpart C—Facilities"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"8fff9e3143bb89dbaf6eb36d1572b8c4a2b48824903f56ea99f94f972bd45c6e","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-58.35","next":"us/21-cfr-58.43"},"notice":"GroundRules: Original legal text. Not legal advice."}